Notice2023-01683
National Institute on Drug Abuse; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 27, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 18 (Friday, January 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 18 (Friday, January 27, 2023)]
[Notices]
[Pages 5364-5366]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01683]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIH
[[Page 5365]]
Support for Conferences and Scientific Meetings.
Date: February 22, 2023.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 827-4471,
<a href="/cdn-cgi/l/email-protection#1163707c7075707f7863517c70787d3f7f78793f767e67"><span class="__cf_email__" data-cfemail="b3c1d2ded2d7d2dddac1f3ded2dadf9ddddadb9dd4dcc5">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Transformative Research on the Basic Mechanisms of
Polysubstance use in Addiction.
Date: February 27, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Scientific Review Branch, Division of Extramural
Research, National Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702,
<a href="/cdn-cgi/l/email-protection#89fae0e7ede1fca7e2e0f3e1e8e2e2ece4e8ede8fde1e0e5c9e7e0e1a7eee6ff"><span class="__cf_email__" data-cfemail="96e5fff8f2fee3b8fdffecfef7fdfdf3fbf7f2f7e2fefffad6f8fffeb8f1f9e0">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA REI: Research on Neurocognitive Mechanisms
Underlying the Impact of Structural Racism on the Substance Use
Trajectory.
Date: March 2, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Stefan Wolff, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 480-1448, <a href="/cdn-cgi/l/email-protection#6406160d050a4a130b080202240a0d0c4a030b12"><span class="__cf_email__" data-cfemail="2d4f5f444c43035a42414b4b6d434445034a425b">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Accelerating the Pace of Drug Abuse Research Using
Existing Data.
Date: March 3, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Li Rebekah Feng, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827-7245, <a href="/cdn-cgi/l/email-protection#fb899e999e909a93d59d9e959cbb959293d59c948d"><span class="__cf_email__" data-cfemail="790b1c1b1c121811571f1c171e39171011571e160f">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Centers Grant Program (P50) (P30).
Date: March 3, 2023.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jenny Raye Browning, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 443-4577,
<a href="/cdn-cgi/l/email-protection#0a606f646473246878657d6463646d4a646362246d657c"><span class="__cf_email__" data-cfemail="a7cdc2c9c9de89c5d5c8d0c9cec9c0e7c9cecf89c0c8d1">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Centers Grant Program (P50) (P30).
Date: March 6-7, 2023.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sheila Pirooznia, Ph.D., Scientific Review
Officer, Scientific Review, Branch Division of Extramural Review,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 496-9350,
<a href="/cdn-cgi/l/email-protection#03706b666a6f622d736a716c6c796d6a62436d6a6b2d646c75"><span class="__cf_email__" data-cfemail="ef9c878a86838ec19f869d80809581868eaf818687c1888099">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Therapeutic Development of Psychoplastogenic
Compounds for Substance Use Disorders.
Date: March 7, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Stefan Wolff, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 480-1448, <a href="/cdn-cgi/l/email-protection#accedec5cdc282dbc3c0cacaecc2c5c482cbc3da"><span class="__cf_email__" data-cfemail="b9dbcbd0d8d797ced6d5dfdff9d7d0d197ded6cf">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Device-Based Treatments for Substance Use Disorders.
Date: March 8, 2023.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Preethy Nayar, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 443-
4577, <a href="/cdn-cgi/l/email-protection#90fef1e9f1e2e0a2d0f3e3e2befef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="a1cfc0d8c0d3d193e1c2d2d38fcfc8c98fc6ced7">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Initial
Review Group; Career Development Education and Training Study
Section.
Date: March 9, 2023.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Scientific Review Branch, Division of Extramural
Research, National Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702,
<a href="/cdn-cgi/l/email-protection#65160c0b010d104b0e0c1f0d040e0e0008040104110d0c09250b0c0d4b020a13"><span class="__cf_email__" data-cfemail="f98a90979d918cd7929083919892929c94989d988d919095b9979091d79e968f">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Chemical Countermeasures Research Program (CCRP)
Initiative: Basic Research on The Deleterious Effects of Acute
Exposure to Ultra-Potent Synthetic (UPS) Opioids.
Date: March 9, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Li Rebekah Feng, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827-7245, <a href="/cdn-cgi/l/email-protection#74061116111f151c5a12111a13341a1d1c5a131b02"><span class="__cf_email__" data-cfemail="bfcddadddad4ded791d9dad1d8ffd1d6d791d8d0c9">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Initial
Review Group; Medication Development Research Study Section.
Date: March 15, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Preethy Nayar, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, 301-443-
4577, <a href="/cdn-cgi/l/email-protection#701e110911020042301303025e1e19185e171f06"><span class="__cf_email__" data-cfemail="e08e8199819290d2a0839392ce8e8988ce878f96">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA REI: Racial Equity Visionary Award Program for
Research on Substance Use and Racial Equity.
Date: March 16-17, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sheila Pirooznia, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Review,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021,
[[Page 5366]]
Bethesda, MD 20892, (301) 496-9350, <a href="/cdn-cgi/l/email-protection#5e2d363b37323f702e372c31312430373f1e30373670393128"><span class="__cf_email__" data-cfemail="1f6c777a76737e316f766d70706571767e5f71767731787069">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 23, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-01683 Filed 1-26-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 27, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.